Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: implications for personalized cancer therapy.
about
Proteomics of ovarian cancer: functional insights and clinical applicationsTherapeutic potential of TAS-115 via c-MET and PDGFRα signal inhibition for synovial sarcoma.4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer.The promise and challenge of ovarian cancer models.Novel high-grade serous epithelial ovarian cancer cell lines that reflect the molecular diversity of both the sporadic and hereditary diseaseImmunocapture strategies in translational proteomics.Characterization of ovarian clear cell carcinoma using target drug-based molecular biomarkers: implications for personalized cancer therapy.Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies.Using reverse-phase protein arrays as pharmacodynamic assays for functional proteomics, biomarker discovery, and drug development in cancer.Signaling pathway profiling using reverse-phase protein array and its clinical applications.Reverse phase protein array (RPPA) combined with computational analysis to unravel relevant prognostic factors in non- small cell lung cancer (NSCLC): a pilot study.Kinase-driven metabolic signalling as a predictor of response to carboplatin-paclitaxel adjuvant treatment in advanced ovarian cancers.
P2860
Q28082632-E9F1F85B-4FCB-4CD8-B540-46207F6738B3Q33696791-4A5FDB6E-DA49-4881-B3EB-3CE51817B6DFQ35749170-99D26B4C-5D41-4268-ABA7-7FB0E4B12C6EQ35771750-38F90C9D-AA67-4BDC-92BA-B288926B538DQ36248459-8C5606D3-2832-4608-ABBD-81E7DD213A10Q36519000-385D96C6-BF96-4FB4-92F4-C891C096A1B5Q37637147-221E3D2F-D39C-42A0-95F0-CEBDE5C68001Q38722976-53229E8D-F188-497F-A775-F2D7508C9406Q38963132-03ADF539-88D2-4697-8AFD-BA4E5AAD0646Q39377837-272EFE0F-8D88-48AF-8347-41D2F89C513DQ44239255-D228627B-EBC8-41EB-BFDB-0D17D62C4199Q50915266-340C1F59-5E05-4D53-A741-8C72EA59FC0B
P2860
Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: implications for personalized cancer therapy.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Functional characterization of ...... r personalized cancer therapy.
@ast
Functional characterization of ...... r personalized cancer therapy.
@en
type
label
Functional characterization of ...... r personalized cancer therapy.
@ast
Functional characterization of ...... r personalized cancer therapy.
@en
prefLabel
Functional characterization of ...... r personalized cancer therapy.
@ast
Functional characterization of ...... r personalized cancer therapy.
@en
P2093
P2860
P50
P356
P1433
P1476
Functional characterization of ...... r personalized cancer therapy.
@en
P2093
Eliana Bignotti
Elisa Baldelli
Elisabetta Bandiera
Emanuel Petricoin
Francesco Meani
Germana Tognon
Guido Gambara
Jianghong Deng
Lance A Liotta
Maria Isabella Sereni
P2860
P304
P356
10.1002/PMIC.201400214
P577
2015-01-01T00:00:00Z